Christopher Bishop

Behavioral Neuroscience Program, Binghamton University

Research Area

Neuroscience

Biography

Christopher Bishop has not added Biography.
If you are Christopher Bishop and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2021

Other Publications

Article	Year
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation. The European journal of neuroscience\| PubMed ID: 16817869	2006
Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats. Journal of neuroscience research\| PubMed ID: 19115412	2009
Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia. Neuroreport\| PubMed ID: 19633584	2009
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Experimental neurology\| PubMed ID: 21352823	2011
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 21402691	2011
Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology\| PubMed ID: 21635907	2011
Enhancement of the hypothalamic-pituitary-adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague-Dawley rats. Psychopharmacology\| PubMed ID: 21735074	2011
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats. Pharmacology, biochemistry, and behavior\| PubMed ID: 21978941	2012
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats. The European journal of neuroscience\| PubMed ID: 22762478	2012
The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat. Psychopharmacology\| PubMed ID: 23389756	2013
Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats. ACS chemical neuroscience\| PubMed ID: 23496922	2013
The impact of ventral noradrenergic bundle lesions on increased IL-1 in the PVN and hormonal responses to stress in male sprague dawley rats. Endocrinology\| PubMed ID: 23671261	2013
Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease. Brain research\| PubMed ID: 24060645	2013
Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats. Neuropharmacology\| PubMed ID: 24067924	2014
Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease. Neuroscience and biobehavioral reviews\| PubMed ID: 24113323	2013
Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat. Behavioural brain research\| PubMed ID: 24837745	2014
Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleus. Neuropharmacology\| PubMed ID: 25817388	2015
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat. Journal of neurochemistry\| PubMed ID: 25866285	2015
Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia. Neuroscience\| PubMed ID: 26363150	2015
Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats. Pharmacology, biochemistry, and behavior\| PubMed ID: 26791104	2016
A working model for the assessment of disruptions in social behavior among aged rats: The role of sex differences, social recognition, and sensorimotor processes. Experimental gerontology\| PubMed ID: 26811912	2016
Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats. Neuropharmacology\| PubMed ID: 27452719	2016
The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 27656025	2016
Characterizing the differential roles of striatal 5-HT auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia. Experimental neurology\| PubMed ID: 28342749	2017
Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model. Movement disorders : official journal of the Movement Disorder Society\| PubMed ID: 28631864	2017
D-512, a novel dopamine D receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats. British journal of pharmacology\| PubMed ID: 28667675	2017
Serotonergic targets for the treatment of L-DOPA-induced dyskinesia. Journal of neural transmission (Vienna, Austria : 1996)\| PubMed ID: 29305656	2018
Striatal norepinephrine efflux in l-DOPA-induced dyskinesia. Neurochemistry international\| PubMed ID: 29371053	2018
A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia. Neuroscience and biobehavioral reviews\| PubMed ID: 29782883	2018
Behavioral and cellular dopamine D and D receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. Neuropharmacology\| PubMed ID: 29936243	2018
Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats. Movement disorders : official journal of the Movement Disorder Society\| PubMed ID: 30485908	2018
Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia. Acta neuropathologica communications\| PubMed ID: 30646956	2019
Biased G Protein-Independent Signaling of Dopamine D-D Receptor Heteromers in the Nucleus Accumbens. Molecular neurobiology\| PubMed ID: 30919214	2019
Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat. Neuroscience\| PubMed ID: 31029732	2019
Late aging-associated increases in L-DOPA-induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat. Neurobiology of aging\| PubMed ID: 31306813	2019
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat. Psychopharmacology\| PubMed ID: 31435690	2020
Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia. Movement disorders : official journal of the Movement Disorder Society\| PubMed ID: 31845761	2019
Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease. Frontiers in pharmacology\| PubMed ID: 32009944	2019
Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats. Experimental neurology\| PubMed ID: 32387398	2020
Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats. Neuropharmacology\| PubMed ID: 32492451	2020
Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia. Experimental neurology\| PubMed ID: 33249031	2021
Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats. The European journal of neuroscience\| PubMed ID: 33426708	2021
Combined Knockout of Lrrk2 and Rab29 Does Not Result in Behavioral Abnormalities in vivo. Journal of Parkinson's disease\| PubMed ID: 33523017	2021